Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian Lewis is active.

Publication


Featured researches published by Brian Lewis.


Journal of Homeland Security and Emergency Management | 2011

A Social Vulnerability Index for Disaster Management

Barry Flanagan; Edward W. Gregory; Elaine J. Hallisey; Janet L. Heitgerd; Brian Lewis

Social vulnerability refers to the socioeconomic and demographic factors that affect the resilience of communities. Studies have shown that in disaster events the socially vulnerable are more likely to be adversely affected, i.e. they are less likely to recover and more likely to die. Effectively addressing social vulnerability decreases both human suffering and the economic loss related to providing social services and public assistance after a disaster. This paper describes the development of a social vulnerability index (SVI), from 15 census variables at the census tract level, for use in emergency management. It also examines the potential value of the SVI by exploring the impact of Hurricane Katrina on local populations.


Morbidity and Mortality Weekly Report | 2017

Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015

Gery P. Guy; Kun Zhang; Michele K. Bohm; Jan L. Losby; Brian Lewis; Randall Young; Louise B. Murphy; Deborah Dowell

Background Prescription opioid–related overdose deaths increased sharply during 1999–2010 in the United States in parallel with increased opioid prescribing. CDC assessed changes in national-level and county-level opioid prescribing during 2006–2015. Methods CDC analyzed retail prescription data from QuintilesIMS to assess opioid prescribing in the United States from 2006 to 2015, including rates, amounts, dosages, and durations prescribed. CDC examined county-level prescribing patterns in 2010 and 2015. Results The amount of opioids prescribed in the United States peaked at 782 morphine milligram equivalents (MME) per capita in 2010 and then decreased to 640 MME per capita in 2015. Despite significant decreases, the amount of opioids prescribed in 2015 remained approximately three times as high as in 1999 and varied substantially across the country. County-level factors associated with higher amounts of prescribed opioids include a larger percentage of non-Hispanic whites; a higher prevalence of diabetes and arthritis; micropolitan status (i.e., town/city; nonmetro); and higher unemployment and Medicaid enrollment. Conclusions and Implications for Public Health Practice Despite reductions in opioid prescribing in some parts of the country, the amount of opioids prescribed remains high relative to 1999 levels and varies substantially at the county-level. Given associations between opioid prescribing, opioid use disorder, and overdose rates, health care providers should carefully weigh the benefits and risks when prescribing opioids outside of end-of-life care, follow evidence-based guidelines, such as CDC’s Guideline for Prescribing Opioids for Chronic Pain, and consider nonopioid therapy for chronic pain treatment. State and local jurisdictions can use these findings combined with Prescription Drug Monitoring Program data to identify areas with prescribing patterns that place patients at risk for opioid use disorder and overdose and to target interventions with prescribers based on opioid prescribing guidelines.


Journal of Acquired Immune Deficiency Syndromes | 2016

County-level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections among Persons who Inject Drugs, United States

Michelle Van Handel; Charles E. Rose; Elaine J. Hallisey; Jessica L. Kolling; Jon E. Zibbell; Brian Lewis; Michele K. Bohm; Christopher M. Jones; Barry Flanagan; Azfar-e-Alam Siddiqi; Kashif Iqbal; Andrew Dent; Jonathan Mermin; Eugene McCray; John W. Ward; John T. Brooks

Objective:A recent HIV outbreak in a rural network of persons who inject drugs (PWID) underscored the intersection of the expanding epidemics of opioid abuse, unsterile injection drug use (IDU), and associated increases in hepatitis C virus (HCV) infections. We sought to identify US communities potentially vulnerable to rapid spread of HIV, if introduced, and new or continuing high rates of HCV infections among PWID. Design:We conducted a multistep analysis to identify indicator variables highly associated with IDU. We then used these indicator values to calculate vulnerability scores for each county to identify which were most vulnerable. Methods:We used confirmed cases of acute HCV infection reported to the National Notifiable Disease Surveillance System, 2012–2013, as a proxy outcome for IDU, and 15 county-level indicators available nationally in Poisson regression models to identify indicators associated with higher county acute HCV infection rates. Using these indicators, we calculated composite index scores to rank each countys vulnerability. Results:A parsimonious set of 6 indicators were associated with acute HCV infection rates (proxy for IDU): drug-overdose deaths, prescription opioid sales, per capita income, white, non-Hispanic race/ethnicity, unemployment, and buprenorphine prescribing potential by waiver. Based on these indicators, we identified 220 counties in 26 states within the 95th percentile of most vulnerable. Conclusions:Our analysis highlights US counties potentially vulnerable to HIV and HCV infections among PWID in the context of the national opioid epidemic. State and local health departments will need to further explore vulnerability and target interventions to prevent transmission.


Environmental Health Perspectives | 2009

A Review of Events That Expose Children to Elemental Mercury in the United States

Robin Lee; Dan Middleton; Kathleen L. Caldwell; Steve M Dearwent; Steven K. Jones; Brian Lewis; Carolyn Monteilh; Mary E. Mortensen; Richard Nickle; Kenneth Orloff; Meghan Reger; John F. Risher; Helen Schurz Rogers; Michelle Watters

Objective Concern for children exposed to elemental mercury prompted the Agency for Toxic Substances and Disease Registry and the Centers for Disease Control and Prevention to review the sources of elemental mercury exposures in children, describe the location and proportion of children affected, and make recommendations on how to prevent these exposures. In this review, we excluded mercury exposures from coal-burning facilities, dental amalgams, fish consumption, medical waste incinerators, or thimerosal-containing vaccines. Data sources We reviewed federal, state, and regional programs with information on mercury releases along with published reports of children exposed to elemental mercury in the United States. We selected all mercury-related events that were documented to expose (or potentially expose) children. We then explored event characteristics (i.e., the exposure source, location). Data synthesis Primary exposure locations were at home, at school, and at other locations such as industrial property not adequately remediated or medical facilities. Exposure to small spills from broken thermometers was the most common scenario; however, reports of such exposures are declining. Discussion and conclusions Childhood exposures to elemental mercury often result from inappropriate handling or cleanup of spilled mercury. The information reviewed suggests that most releases do not lead to demonstrable harm if the exposure period is short and the mercury is properly cleaned up. Recommendations Primary prevention should include health education and policy initiatives. For larger spills, better coordination among existing surveillance systems would assist in understanding the risk factors and in developing effective prevention efforts.


Ciencia & Saude Coletiva | 2010

A review of events that expose children to elemental mercury in the United States

Robin Lee; Dan Middleton; Kathleen L. Caldwell; Steve M. Dearwent; Steven Jones; Brian Lewis; Carolyn Monteilh; Mary E. Mortensen; Richard Nickle; Kenneth Orloff; Meghan Reger; John F Risher; Helen Schurz Rogers; Michelle Watters

Concern for children exposed to elemental mercury prompted the Agency for Toxic Substances and Disease Registry and the Centers for Disease Control and Prevention to review the sources of elemental mercury exposures in children, describe the location and proportion of children affected, and make recommendations on how to prevent these exposures. In this review, we excluded mercury exposures from coal-burning facilities, dental amalgams, fish consumption, medical waste incinerators, or thimerosal-containing vaccines. We reviewed federal, state, and regional programs with data on mercury releases along with published reports of children exposed to elemental mercury in the United States. We selected all mercury-related events that were documented to expose (or potentially expose) children. Primary exposure locations were at home, at school, and at others such as industrial property not adequately remediated or medical facilities. Exposure to small spills from broken thermometers was the most common scenario; however, reports of such exposures are declining. The information reviewed suggests that most releases do not lead to demonstrable harm if the exposure period is short and the mercury is properly cleaned up. Primary prevention should include health education and policy initiatives.


Cancer Epidemiology, Biomarkers & Prevention | 2009

Use of Molecular Testing to Identify a Cluster of Patients with Polycythemia Vera in Eastern Pennsylvania

Vincent Seaman; Aisha O. Jumaan; Emad Yanni; Brian Lewis; Jonathan Neyer; Paul Roda; Mingjiang Xu; Ronald Hoffman

Background: The role of the environment in the origin of polycythemia vera has not been well documented. Recently, molecular diagnostic tools have been developed to facilitate the diagnosis of polycythemia vera. A cluster of patients with polycythemia vera was suspected in three countries in eastern Pennsylvania where there have long been a concern about environment hazards. Methods: Rigorous clinical criteria and JAK2 617V>F testing were used to confirm the diagnosis of polycythemia vera in patients in this area. Participants included cases of polycythemia vera from the 2001 to 2005 state cancer registry as well as self- and physician-referred cases. Finding: A diagnosis of polycythemia vera was confirmed in 53% of 62 participants using WHO criteria, which includes JAK2 617V>F testing. A statistically significant cluster of cases (P < 0.001) was identified where the incidence of polycythemia vera was 4.3 times that of the rest of the study area. The area of the cluster contained numerous sources of hazardous material including waste-coal power plants and U.S. Environmental Protection Agency Superfund sites. Interpretation: The diagnosis of polycythemia vera based solely on clinical criteria is frequently erroneous, suggesting that our prior knowledge of the epidemiology of this disease might be inaccurate. The JAK2 617V>F mutational analysis provides diagnostic clarity and permitted the confirmation of a cluster of polycythemia vera cases not identified by traditional clinical and pathologic diagnostic criteria. The close proximity of this cluster to known areas of hazardous material exposure raises concern that such environmental factors might play a role in the origin of polycythemia vera. (Cancer Epidemiol Biomarkers Prev 2009;18(2):534–40)


International Journal of Environmental Research and Public Health | 2010

A multidisciplinary investigation of a polycythemia vera cancer cluster of unknown origin.

Vincent Seaman; Steve M Dearwent; Debra Gable; Brian Lewis; Susan Metcalf; Ken Orloff; Bruce C. Tierney; Jane Zhu; James N. Logue; David Marchetto; Stephen Ostroff; Ronald Hoffman; Mingjiang Xu; David J. Carey; Porat M. Erlich; Glenn S. Gerhard; Paul Roda; Joseph Iannuzzo; Robert Lewis; John Mellow; Linda Mulvihill; Zachary Myles; Manxia Wu; Arthur L. Frank; Carol Ann Gross-Davis; Judith Klotz; Adam Lynch; Joel L. Weissfeld; Rona S. Weinberg; Henry Cole

Cancer cluster investigations rarely receive significant public health resource allocations due to numerous inherent challenges and the limited success of past efforts. In 2008, a cluster of polycythemia vera, a rare blood cancer with unknown etiology, was identified in northeast Pennsylvania. A multidisciplinary group of federal and state agencies, academic institutions, and local healthcare providers subsequently developed a multifaceted research portfolio designed to better understand the cause of the cluster. This research agenda represents a unique and important opportunity to demonstrate that cancer cluster investigations can produce desirable public health and scientific outcomes when necessary resources are available.


Journal of Community Health | 2011

Time and Distance Barriers to Mammography Facilities in the Atlanta Metropolitan Area

Lucy A. Peipins; Shannon Graham; Randall Young; Brian Lewis; Stephanie Foster; Barry Flanagan; Andrew Dent


Archive | 2010

Recovery after Katrina : deconstructing the map

Elaine J. Hallisey; Barry Flanagan; Edward W. Gregory; Brian Lewis


Archive | 2009

A review of events that expose children to elemental mercury in the United States Uma revisão dos eventos que expõem as crianças ao elemento mercúrio nos Estados Unidos

Robin Lee; Dan Middleton; Kathleen L. Caldwell; Steve M Dearwent; Steven K. Jones; Brian Lewis; Carolyn Monteilh; Mary E. Mortensen; Richard Nickle; Kenneth Orloff; Meghan Reger; John F Risher; Helen Schurz Rogers; Michelle Watters

Collaboration


Dive into the Brian Lewis's collaboration.

Top Co-Authors

Avatar

Barry Flanagan

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Helen Schurz Rogers

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Kathleen L. Caldwell

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Mary E. Mortensen

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Roda

Geisinger Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Steve M Dearwent

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Vincent Seaman

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Aisha O. Jumaan

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge